IP Library Granted Patent US 8,012,736
Granted Patent B2
US 8,012,736 · App. 10/423,828 · Granted Sep 6, 2011

Multi plasmid system for the production of influenza virus

Assignee: Medimmune, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,012,736
App. No.
10/423,828
Granted
Sep 6, 2011
Kind
B2
Abstract

Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided.

Claims (14)

1. A helper virus free method for producing infectious influenza B viruses in cell culture, the method comprising:

i) electroporating a population of Vero cells with a plurality of plasmids comprising nucleic acid sequences corresponding to an influenza B virus genome;

ii) culturing the population of Vero cells under conditions permissive for viral replication in the absence of helper virus; and,

iii) recovering a plurality of infectious influenza B viruses.

2. The method of claim 1 , wherein the influenza B viruses possess one or more phenotypic attributes selected from the group consisting of: attenuation, temperature sensitivity and cold adaptation.

3. The method of claim 1 , wherein the influenza B viruses comprise an attenuated, cold adapted, temperature sensitive influenza virus.

4. The method of claim 1 , wherein the influenza B virus is suitable for administration in an intranasal vaccine formulation.

5. The method of claim 1 , comprising culturing the population of host cells at a temperature less than or equal to 35° C.

6. The method of claim 1 , comprising culturing the Vero cells in serum free medium.

7. The method of claim 1 wherein the plurality of plasmids is eight plasmids.

8. A helper virus free method for producing infectious influenza B viruses in cell culture, the method comprising:

i) electroporating a population of Vero cells with eight plasmids comprising nucleic acid sequences corresponding to an influenza B virus genome encoding an attenuated, cold adapted, temperature sensitive influenza virus;

ii) culturing the population of Vero cells under conditions permissive for viral replication in the absence of helper virus at a temperature less than or equal to 35° C. and in serum free medium; and,

iii) recovering a plurality of infectious influenza B viruses.

Assignments (3)
CHANGE OF NAME Recorded Oct 22, 2008
From: MEDIMMUNE VACCINES, INC.
To: MEDIMMUNE, INC.
Reel/Frame 021718/0076 →
CHANGE OF NAME Recorded Oct 22, 2008
From: MEDIMMUNE, INC.
To: MEDIMMUNE, LLC
Reel/Frame 021718/0130 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2003
From: HOFFMAN, ERICH; JIN, HONG; LU, BIN; DUKE, GREG; KEMBLE, GEORGE
To: MEDLMMUNE VACCINES, INC.
Reel/Frame 014533/0806 →
Continuity (7)
Provisional Application 60394983 · Jul 9, 2002
Provisional Application 60410576 · Sep 12, 2002
Provisional Application 60419802 · Oct 18, 2002
Provisional Application 60420708 · Oct 23, 2002
Provisional Application 60457699 · Mar 24, 2003
Provisional Application 60462361 · Apr 10, 2003
Related Publication 20040029251A1 · Feb 12, 2004